Viridian Therapeutics VRDN - Options Chain | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Viridian Therapeutics Inc (VRDN)
Viridian Therapeutics Inc (VRDN) Options

Viridian Therapeutics Inc (VRDN)

15.43

0.29

(1.92%)

Closed 20 March 7:00AM

Delayed by 15 minutes

14.50

-0.93

( -6.03% )

Pre Market: 7:29PM

Delayed by 15 minutes

VRDN Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	10.50	15.00	0.00	12.75	0.00	0.00 %	0	0	-
5.00	8.00	12.50	0.00	10.25	0.00	0.00 %	0	0	-
7.50	5.60	9.70	0.00	7.65	0.00	0.00 %	0	0	-
10.00	4.30	6.60	0.00	5.45	0.00	0.00 %	0	0	-
12.50	0.60	4.80	0.00	2.70	0.00	0.00 %	0	0	-
15.00	0.10	4.30	1.09	2.20	0.00	0.00 %	0	3	-
17.50	0.58	0.20	0.58	0.39	0.00	0.00 %	0	113	-
20.00	0.01	1.50	0.01	0.755	0.00	0.00 %	0	22	-
22.50	0.34	0.25	0.34	0.295	0.00	0.00 %	0	179	-
25.00	0.20	1.45	0.20	0.825	0.00	0.00 %	0	10	-
30.00	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	1.55	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.90	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.00	0.95	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.10	1.30	0.15	0.70	0.00	0.00 %	0	146	-
17.50	0.85	4.20	2.17	2.525	0.00	0.00 %	0	6	-
20.00	2.85	7.00	0.00	4.925	0.00	0.00 %	0	0	-
22.50	5.10	9.50	0.00	7.30	0.00	0.00 %	0	0	-
25.00	7.60	12.00	0.00	9.80	0.00	0.00 %	0	0	-
30.00	12.70	17.00	0.00	14.85	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SAGSAG Holdings Ltd	US$ 1.22 (80.74%)	4.91M
OPTNOptiNose Inc	US$ 9.56 (59.33%)	102.49k
AGMHAGM Group Holdings Inc	US$ 0.1039 (44.31%)	21.27M
LEELee Enterprises Inc	US$ 11.99 (36.72%)	4
IDYAIDEAYA Biosciences Inc	US$ 23.99 (31.74%)	6
CSQCalamos Strategic Total Return Fund	US$ 10.01 (-39.52%)	1
ZCARZoomcar Holdings Inc	US$ 0.219 (-28.64%)	59.43k
HCSGHealthcare Services Group Inc	US$ 8.00 (-26.81%)	203
AKBAAkebia Therapeutics Inc	US$ 2.18 (-23.24%)	16k
NEHCNew Era Helium Inc	US$ 2.00 (-20.32%)	20
AGMHAGM Group Holdings Inc	US$ 0.1039 (44.31%)	21.27M
BTOGBit Origin Ltd	US$ 0.315 (18.91%)	5.37M
SAGSAG Holdings Ltd	US$ 1.22 (80.74%)	4.91M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 8.41 (3.32%)	3.26M
BDTXBlack Diamond Therapeutics Inc	US$ 2.01 (16.86%)	1.39M

Monksdream

Monksdream 6 months ago

VRDN more upside possible

it_happens

it_happens 6 months ago

Touched 20s today. Maybe it will stay above 20 tomorrow

power11

power11 6 months ago

LOW 20'S BY WEEKEND IMO !!!
GOOD LUCK

it_happens

it_happens 6 months ago

Good news. I don't think that this is merely a one-day runner.

power11

power11 6 months ago

BTIG RESEARCH ADJUST PRICE TARGET TO 56 FROM 46; STRONG BUY !!

it_happens

it_happens 6 months ago

Over 15 and having a good day today

Monksdream

Monksdream 6 months ago

Apprentice

Apprentice 3 years ago

I put into it a lot of $
423 shares!

Apprentice

Apprentice 3 years ago

It just doesn't want to move above $18
Yet, it's not diving much either.
What do you think at this point? Sell temporarily and by later low?
My average is too high @17.76 !

crudeoil24

crudeoil24 3 years ago

Viridian Therapeutics, Inc., formerly Miragen Therapeutics, Inc., is a biotechnology company. The Company is engaged in developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications. Its lead candidate, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody (mAb) that is under development for thyroid eye disease (TED). The Company's TED pipeline also includes VRDN-002 and VRDN-003. Its other programs include VRDN-004, which is under development for undisclosed rare orphan disease, and VRDN-005, which is under development for tick-borne disease (TBD). The Company also out licenses its programs.

Viridian Therapeutics

United States Natural Gas

Royal Canadian Mint Cana...

Exco Technologies

Euronext Core Europe 100...

WisdomTree US Value

Vanguard Ftse Developed ...

MetroCity Bankshares

Desjardins Canadian Pref...

Construction Partners

Bot Zc Aug25 A Eur

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions